The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy

Recruiting now · Not applicable

Conditions studied: Epilepsy

In brief

Neuronostics plan a prospective multisite trial to determine the clinical utility of BioEP in the context of diagnostic decision making. Neuronostics will use findings from the trial to improve user experience of the Neuronostics platform (the tool which clinicians use to obtain a BioEP score from EEG and the aligned report). The data coming from the trial will also enable Neuronostics to iterate the BioEP algorithms and so improve future performance.

Key facts

Study ID

NCT06097195

Run by

Neuronostics Ltd

People needed

559

Starts

2024-05-21

Expected to finish

2026-12-31

Last updated by the study team

2026-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (age 18 and above) presenting with first suspected seizure(s)
• Able to give informed consent
• Patient receives EEG following clinicians' decision to refer for an EEG based on clinical history and seizure description taken during first seizure clinic.
• Non-contributory EEG only (i.e. no specific diagnostic abnormalities present such as interictal epileptiform discharges)

You may not qualify if…

• Participants unable to tolerate an EEG test so no EEG data were gathered
• Participants with a known hepatic/renal encephalopathy
• Participants that upon history taking have a clear clinical diagnosis of a physical condition other than epilepsy (e.g. vasovagal syncope)

Where it is running

• Royal Cornwall Hospitals Trust — Truro, United Kingdom (enrolling)
• The Royal Wolverhampton NHS Trust — Wolverhampton, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.